← Back to headlines
CDT Equity Moves AstraZeneca's AZD5904 to PCT Patent Stage
CDT Equity has advanced AstraZeneca PLC (AZN)’s compound AZD5904 into the Patent Cooperation Treaty (PCT) patent protection stage.
11 May, 20:01 — 11 May, 20:01
Sources
Showing 1 of 1 sources
